VetSheet

Atropine

Atropine sulfate

Anticholinergic / ParasympatholyticIMIVOphthalmicDogsCats

Also known as: Atrocare Β· Minims Atropine Β· Atropinum Β· Atropine sulphate Β· Atropine sulfate Β· Atropina

Reviewed by the VetSheet Veterinary TeamUpdated Apr 5, 2026Evidence-based veterinary reference

Audited v13 dosing evidence

Reviewed non-calculator evidence
Reviewed non-calculator evidence (1)

Evidence only β€” not for automatic calculation

Premedication and treatment of vagally-mediated bradycardia

Premedication and treatment of vagally-mediated bradycardia: 0.04 – 0.05 mg/kg IV, SC, or IM 29 or intratracheally for CPR

IMIVSCintratracheal
Governing clinical context (2)
  • NOTE: FDA approval has not been required for atropine products in animals. All dosages should be considered extra-label.
  • Atropine sulfate for injection should be stored at room temperature between 15Β°C and 30Β°C (59Β°F-86Β°F).
High riskVerified clinician requiredreviewed_narrativeProtocol 2023Audit dose-audit-plumb-v13

Doses are a clinical reference for licensed veterinary professionals. Always confirm against the current label and the individual patient.

Recording this consult? VetSheet's AI writes the drug, dose and duration straight into a structured visit note.See how VetSheet works

Overview

Atropine is a classic anticholinergic agent used primarily in veterinary medicine to treat bradycardia, dilate pupils for ophthalmic examinations, and manage specific toxicities (such as organophosphate and carbamate poisoning). It is also used in conjunction with anticholinesterase drugs during the antagonism of neuromuscular blockade.

​Clinical Warning:​ Routine administration prior to anaesthesia as part of premedication is no longer recommended. It is better to monitor heart rate and administer atropine specifically to manage a low heart rate if necessary.

Mechanism of action

Atropine competitively blocks the action of acetylcholine at muscarinic receptors located at the terminal ends of the parasympathetic nervous system.

This blockade β†’ reverses parasympathetic effects β†’ produces mydriasis (pupil dilation), tachycardia, bronchodilation, and general inhibition of gastrointestinal function.

Safety & warnings

Contraindications

  • Glaucoma
  • Lens luxation
  • Keratoconjunctivitis sicca (KCS / dry eye)

Adverse effects

  • Sinus tachycardia
  • Blurred vision (due to mydriasis)
  • Drying of bronchial secretions
  • Increased intraocular pressure (IOP)
  • Reduced tear production
  • Ventricular arrhythmias
  • Hypersalivation (especially in cats, due to bitter taste of ophthalmic drops)
  • Ileus (rare in small animals)
  • Vomiting (rare in small animals)

Precautions

Atropine has a slow onset of action (10 min IM, 2-3 min IV); therefore, it is important to wait for an adequate period of time for the desired effect before redosing.

​Clinical Pearl:​ The ophthalmic solution tastes very bitter. If it drains through the nasolacrimal duct into the mouth, it can cause profound hypersalivation, particularly in cats and some dogs.

Blurred vision from mydriasis may worsen recovery from anaesthesia.

Drug interactions

Bromides, iodides, sodium bicarbonate, alkalis, noradrenalineMajor

Incompatible when mixed together

AntihistaminesModerate

May enhance the activity of atropine

PethidineModerate

May enhance the activity of atropine

BenzodiazepinesModerate

May enhance the activity of atropine

PhenothiazinesModerate

May enhance the activity of atropine

Thiazide diureticsModerate

May enhance the activity of atropine

SympathomimeticsModerate

May enhance the activity of atropine

Alpha-2 agonistsMajor

Combining is not recommended

AmitrazMajor

May aggravate toxicity signs, leading to hypertension and gut stasis

Tricyclic AntidepressantsModerate

Additive anticholinergic effects

Alpha-2 Agonists (e.g., Dexmedetomidine)Major

May cause paradoxical hypertension and significantly increased myocardial workload; concurrent use is generally discouraged

MetoclopramideModerate

Atropine antagonizes the prokinetic effects of metoclopramide on the GI tract

Monitoring

  • Heart rate and rhythm (ECG)
  • Pupillary light reflex and pupil size
  • Intraocular pressure (IOP)
  • Tear production (Schirmer Tear Test)

Pharmacokinetics

Absorption

Slow onset of action: 10 minutes via IM route, 2-3 minutes via IV route.

Overdose

Overdose may lead to severe sinus tachycardia, ventricular arrhythmias (which may be treated with lidocaine if severe), extreme mydriasis, severe drying of secretions, and gastrointestinal stasis.

Available products

Formulations

  • Injectable: 0.6 mg/ml
  • Ophthalmic: 1% solution in single-use vials, 10 ml bottle

Veterinary

  • Atrocare Injectable 0.6 mg/ml
  • Atropine Ophthalmic 1% solution

Regulatory status

United Statesβœ“ ApprovedPrescription onlyFDA/CVM
πŸ• Dogs🐈 Cats
European Unionβœ“ ApprovedPrescription onlyEMA
πŸ• Dogs🐈 Cats🐴 HorsesπŸ„ Cattle pigsπŸ‘ Sheep

Withdrawal times: cattle meat 14 days Β· cattle milk 3 days

Withdrawal times may vary by specific member state and product formulation.

United Kingdomβœ“ ApprovedPrescription onlyVMD
πŸ• Dogs🐈 Cats🐴 HorsesπŸ„ Cattle pigsπŸ‘ Sheep

POM-V (Prescription Only Medicine - Veterinarian).

No regulatory data for: πŸ‡­πŸ‡° HK Β· πŸ‡ΉπŸ‡Ό TW Β· πŸ‡―πŸ‡΅ JP Β· πŸ‡°πŸ‡· KR Β· πŸ‡¦πŸ‡Ί AU

Storage & stability

The solution should be protected from light. Ophthalmic single-use vials do not contain any antimicrobial preservative; therefore, any remaining solution in the vial should be discarded immediately after use.

Client information

Atropine is often used in emergency situations to stabilize your pet's heart rate or as eye drops to dilate the pupil for examination.

​Note on Eye Drops:​ The ophthalmic solution has a very bitter taste. If the drops drain into the back of the throat, your cat or dog may drool excessively. This is a normal reaction to the taste and is not a sign of toxicity. Protect your pet's eyes from bright light while their pupils are dilated.

VetSheet drug reference is intended for licensed veterinary professionals as a clinical decision-support aid, not a substitute for professional judgement or the manufacturer’s current label.